已发表论文

CASC8  lncRNA 通过下调 miR34a 甲基化促进视网膜母细胞瘤细胞的增殖

 

Authors Yang B, Gu B, Zhang J, Xu L, Sun Y

Received 18 June 2020

Accepted for publication 12 October 2020

Published 30 December 2020 Volume 2020:12 Pages 13461—13467

DOI https://doi.org/10.2147/CMAR.S268380

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Sanjeev Srivastava


Background: CASC8  lncRNA has been proven to be oncogenic in a variety of cancers, but its role in other types of cancer remains unclear. This study was to investigate the role of CASC8  in retinoblastoma (Rb).
Methods: RT-qPCR was performed to determine the expression of CASC8  and miR34a in paired Rb and nontumor tissue. Overexpression of CASC8  and miR34a in Rb cells was achieved to evaluate the interaction between them. Methylation-specific PCR was used to analyze the effect of CASC8  overexpression on MIR34A  gene methylation. CCK8 assays were used to analyze cell proliferation.
Results: The results showed that CASC8  expression was upregulated and miR34a expression downregulated in Rb tissue. Moreover, miR34a expression was negatively correlated with the of CASC8  expression in Rb tissue. Overexpression of CASC8  decreased expression of miR34a and increased methylation of MIR 34A  in Rb cells. In addition, overexpression of CASC8  reduced the inhibitory effects of miR34a on Rb-cell proliferation.
Conclusion: CASC8  may promote Rb cell proliferation by downregulating miR34a methylation.
Keywords: retinoblastoma, CASC8 , miR34a, methylation, proliferation